FMP

FMP

Enter

2EM.DE - Ergomed plc

Financial Summary of Ergomed plc(2EM.DE), Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monit

photo-url-https://financialmodelingprep.com/image-stock/2EM.DE.png

Ergomed plc

2EM.DE

XETRA

Inactive Equity

Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, Asia, and Australia. It operates through two segments, Clinical Research Services and Pharmacovigilance. The company provides and manages clinical development, post-approval management, and pharmacovigilance services for pharmaceutical, biotechnology, and generics companies. It focuses on various therapeutic areas, including oncology, haematology, allergy, respiratory, and neurology/CNS, as well as develops orphan drugs. The company also provides site support services. The company was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.

11 EUR

0 (0%)

About

ceo

Dr. Miroslav Reljanovic

sector

Healthcare

industry

Biotechnology

website

https://www.ergomedplc.com

exchange

XETRA

Description

Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, Asia, and Australia. It operates through two segments, Clinical Research Services and Pharmacovigilance. The company provides and manages clinical development, post-approval management, and pharmacovigilance services for pharmaceutical, biotechnology, and generics companies. It focuses on various therapeutic areas, including oncology, haematology, allergy, respiratory, and neurology/CNS, as well as develops orphan drugs. The company also provides site support s...

CIK

N/A

ISIN

N/A

CUSIP

N/A

Address

Surrey Research Park

Phone

44 1483 503 205

Country

GB

Employee

1,400

IPO Date

Aug 26, 2015

Summary

CIK

-

Exchange

XETRA

Industry

Biotechnology

Sector

Healthcare

CUSIP

-

ISIN

-

Country

GB

Price

11

Beta

0.79

Volume Avg.

305

Market Cap

585.99M

Shares

-

52-Week

11.0-16.1

DCF

0

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

34.38

P/B

-

Website

https://www.ergomedplc.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest 2EM.DE News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep